Bibliographic details
Suh G H, Jung H Y, Lee C U, Choi S, Korean Galantamine Study Group. Economic and clinical benefits of galantamine in the treatment of mild to moderate Alzheimer's disease in a Korean population: a 52-week prospective study. Journal of Korean Medical Science 2008; 23(1): 10-17